Advantech Capital Ii L.p. - Net Worth and Insider Trading

Advantech Capital Ii L.p. Net Worth

The estimated net worth of Advantech Capital Ii L.p. is at least $111 Million dollars as of 2024-06-22. Advantech Capital Ii L.p. is the of TOT Biopharm International Co Ltd and owns about 49,136,800 shares of TOT Biopharm International Co Ltd (HKSE:01875) stock worth over $111 Million. Details can be seen in Advantech Capital Ii L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Advantech Capital Ii L.p. has not made any transactions after 2019-11-08 and currently still holds the listed stock(s).

Transaction Summary of Advantech Capital Ii L.p.

To

Advantech Capital Ii L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Advantech Capital Ii L.p. owns 1 companies in total, including TOT Biopharm International Co Ltd (HKSE:01875) .

Click here to see the complete history of Advantech Capital Ii L.p.’s form 4 insider trades.

Insider Ownership Summary of Advantech Capital Ii L.p.

Ticker Comapny Transaction Date Type of Owner
HKSE:01875 TOT Biopharm International Co Ltd 2019-11-08

Advantech Capital Ii L.p. Latest Holdings Summary

Advantech Capital Ii L.p. currently owns a total of 1 stock. Advantech Capital Ii L.p. owns 49,136,800 shares of TOT Biopharm International Co Ltd (HKSE:01875) as of November 8, 2019, with a value of $111 Million.

Latest Holdings of Advantech Capital Ii L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01875 TOT Biopharm International Co Ltd 2019-11-08 49,136,800 2.25 110,557,800

Holding Weightings of Advantech Capital Ii L.p.


Advantech Capital Ii L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Advantech Capital Ii L.p. has made a total of 1 transactions in TOT Biopharm International Co Ltd (HKSE:01875) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in TOT Biopharm International Co Ltd is the sale of 0 shares on November 8, 2019, which brought Advantech Capital Ii L.p. around $0.

Insider Trading History of Advantech Capital Ii L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Advantech Capital Ii L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Advantech Capital Ii L.p. Ownership Network

Ownership Network List of Advantech Capital Ii L.p.

No Data

Ownership Network Relation of Advantech Capital Ii L.p.

Insider Network Chart

Advantech Capital Ii L.p. Owned Company Details

What does TOT Biopharm International Co Ltd do?

Who are the key executives at TOT Biopharm International Co Ltd?

Advantech Capital Ii L.p. is the of TOT Biopharm International Co Ltd. Other key executives at TOT Biopharm International Co Ltd include 2201 Interest of corporation controlled by you Center Laboratories, Inc. , 2301 Trustee Tricor Trust (hong Kong) Limited , and 2101 Beneficial owner Chengwei Evergreen Capital, LP .

TOT Biopharm International Co Ltd (HKSE:01875) Insider Trades Summary

Over the past 18 months, Advantech Capital Ii L.p. made no insider transaction in TOT Biopharm International Co Ltd (HKSE:01875). Other recent insider transactions involving TOT Biopharm International Co Ltd (HKSE:01875) include a net sale of 0 shares made by Chengwei Evergreen Capital, LP , a net sale of 0 shares made by Tricor Trust (hong Kong) Limited , and a net sale of 0 shares made by Center Laboratories, Inc. .

In summary, during the past 3 months, insiders sold 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TOT Biopharm International Co Ltd (HKSE:01875)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TOT Biopharm International Co Ltd Insider Transactions

No Available Data

Advantech Capital Ii L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Advantech Capital Ii L.p.. Currently GuruFocus does not have mailing address information for Advantech Capital Ii L.p..

Discussions on Advantech Capital Ii L.p.

No discussions yet.